MC
TMO icon

Maplelane Capital’s Thermo Fisher Scientific TMO Stock Holding History

Maplelane Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-65,000
Closed -$7.24M – 197
2013
Q4 		$7.24M Sell
65,000
-107,523
-62% -$10.7M 0.29% 74
2013
Q3 		$15.9M Sell
172,523
-107,477
-38% -$9.72M 0.67% 36
2013
Q2 		$23.7M Buy
+280,000
New +$23.3M 1.49% 14

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Maplelane Capital's TMO Position: Q1 2014 in Review

Maplelane Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2014, closing a stake of 65,000 shares — an estimated $7.24M sold.

Maplelane Capital first reported a position in TMO in Q2 2013 and held it in 3 quarters. The position peaked at $23.7M in Q2 2013. 915 funds tracked by Wall St. Rank hold TMO as of Q1 2014.

  • Maplelane Capital reported no remaining Thermo Fisher Scientific position as of Q1 2014 after selling out during the quarter.
  • Maplelane Capital sold 65,000 Thermo Fisher Scientific shares in Q1 2014, an estimated $7.24M.
  • Maplelane Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 3 quarters.
  • Maplelane Capital's Thermo Fisher Scientific position peaked at $23.7M in Q2 2013.
  • 915 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2014.

Based on Maplelane Capital's 13F filing for Q1 2014, filed 15 May 2014.